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Leptin regulates food intake and energy expenditure by activating the long form of the leptin
receptor (LepRb). Leptin also regulates glucose homeostasis by improving whole-body insulin
sensitivity, but the mechanism remains undefined. Leptin action is mediated by phosphorylation
of several tyrosine residues on LepRb. LepRb-Tyr985 plays an important role in the attenuation of
LepRb signaling. We determined the contribution of LepRb-Tyr985-mediated signals to leptin
action on insulin sensitivity using LepRb-Tyr985 mutant mice (l/l mice). Glucose tolerance and
whole-body insulin-mediated glucose utilization were determined in wild-type (/) and l/l mice.
Glucose tolerance was unaltered between female / and l/l mice but enhanced in the male l/l
mice. Serum insulin concentration was decreased at baseline and 15 min after a glucose injection
in female l/l vs. / mice (P  0.05) but unaltered in the male l/l mice. However, basal and insulin-
stimulated glucose transport in isolated soleus and extensor digitorum longus muscle was similar
between / and l/l mice, indicating skeletal muscle insulin sensitivity in vitro was not enhanced.
Moreover, euglycemic-hyperinsulinemic clamps reveal hepatic, rather than peripheral, insulin sen-
sitivity is enhanced in female l/l mice, whereas male l/l mice display both improved hepatic and
peripheral insulin sensitivity. In conclusion, signals emanating from leptin receptor Tyr985 control
hepatic insulin sensitivity in both female and male l/l mice. Lack of LepRb-Tyr985 signaling enhances
whole-body insulin sensitivity partly through increased insulin action on the suppression of hepatic
glucose production. (Endocrinology 152: 2237–2246, 2011)
The adipose-derived hormone leptin regulates food in-take and energy expenditure. Furthermore, leptin de-
ficiency leads to obesity, infertility and other symptoms of
neuroendocrine failure as well as insulin resistance and
type 2 diabetes as described in humans and obese mouse
models [ob/ob mice (lacking leptin) or db/db mice (lacking
the leptin receptor)] (1–5).
Leptin can regulate glucose homeostasis indirectly, by
modifying the level of adiposity, or directly, by improving
insulin sensitivity. The mechanism by which leptin regu-
lates whole-body insulin sensitivity is incompletely re-
solved. Leptin administration to leptin-deficient ob/ob
mice improves glycemic control before any effect on food
intake or adiposity is observed (6), indicating that changes
in insulin sensitivity are uncoupled from alterations in en-
ergy homeostasis. Leptin also enhances insulin action to
inhibit hepatic glucose production (7). Central adminis-
tration of either leptin or insulin suppresses glucose pro-
duction, independent of changes in circulating levels of
insulin (8, 9), possibly through activation of ATP-sensitive
potassium channels in the hypothalamus (10). Leptin reg-
ulates lipid metabolism by increasing skeletal muscle fatty
acid oxidation via activation of the energy sensor AMP-
activated protein kinase (11, 12). Thus, leptin has major
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effects on hepatic and peripheral metabolism through di-
rect action at the level of these organs and indirect action
via hypothalamic activation of the nervous system.
Leptin binding to the long form of the leptin receptor
(LepRb), expressed primarily in the hypothalamus, results
in phosphorylation of tyrosine sites on the intracellular
domain of the receptor and its associated Janus kinase
(Jak) 2. Three tyrosine residues on LepRb are phosphor-
ylated upon leptin stimulation; Tyr985, Tyr1077, and
Tyr1138 (13, 14). Phosphorylation of Tyr1138 of LepRb
recruits the transcription factor signal transducer and ac-
tivator of transcription (STAT)-3 (15, 16), which leads to
the accumulation of the suppressor of cytokine signaling
3 (SOCS3) (14, 17). Leptin-mediated signals by LepRb-
STAT3 are important for food intake and energy expen-
diture, whereas Tyr1138-independent signals are impor-
tant for glucose homeostasis, growth, and reproduction
(17–19). LepRb-Tyr1077 is involved in the activation of
STAT5 (20). Other pathways, such as the phosphatidyl-
inositol 3-kinase pathway, also originate directly from
Jak2 (21, 22). Phosphorylation of Tyr985 recruits the Src
homology containing tyrosine phosphatase (SHP)-2 to the
LepRb and mediates the majority of ERK activation and
c-fos transcription (14, 15). SOCS3 mediates feedback in-
hibition of leptin receptor signaling by binding to Tyr985
(23). We have previously disrupted the LepRb-SHP2/
SOCS3 pathway in mice by mutating Tyr985 of LepRb (l/l
mice) (24). Although growth and reproductive function
are normal in l/l mice, body fat is decreased in female l/l
mice, consistent with the view of inhibitory signals ema-
nating from Tyr985 of LepRb increase leptin action. We
have also shown that insulin levels in fed female mice are
profoundly reduced by mutating Tyr985 of LepRb, sug-
gesting this site also controls insulin sensitivity. We have
further reported that male l/l mice have similar body
weight and insulin levels compared with / mice. Leptin
levels are, however, decreased despite a similar degree of
adiposity in the male l/l mice.
The mechanism by which leptin enhances insulin sen-
sitivity is incompletely understood. Thus, our aim was to
investigate the signaling pathways involved in the meta-
bolic actions of leptin. We used l/l mice to interrogate
inhibitory signaling pathways emanating directly from the
leptin receptor. We determined whether leptin receptor
signaling alters peripheral or hepatic insulin sensitivity




Animal experiments were approved by the regional animal
ethical committee. Three- to 4-month-old female and male /
and l/l (Leprtm2Mgmj/tm2Mgmj) mice were used (24). Animals were
maintained in a temperature- and light-controlled environment
(12-h light, 12-h dark cycle) and had free access to water and
standard rodent chow. Experiments performed in female mice
were not timed to a specific phase of the estrous cycle.
Glucose tolerance test
Glucose (2 g/kg body weight) was administered to 4-h-fasted
/ and l/l mice by ip injection for the assessment of glucose
tolerance. Blood glucose concentration was measured before the
glucose injection and 15, 30, 60, and 120 min thereafter (One
Touch Ultra glucose meter; Lifescan, Milpitas, CA). Blood sam-
ples were obtained from the tail before the glucose injection and
15 min thereafter for determination of insulin concentration us-
ing an ultrasensitive insulin ELISA kit (Crystal Chem Inc.,
Downers Grove, IL).
Muscle incubation procedure and blood collection
Mice were fasted for 4 h. Extensor digitorum longus (EDL)
and soleus muscles were removed from anesthetized mice (aver-
tin, 2,2,2-tribromo ethanol and tertiary amyl alcohol at 16 l/g
body weight, ip), and in vitro 2-deoxyglucose transport was as-
sessed as previously described (25). Muscles were incubated
without or with insulin (0.36 and 60 nmol/liter) as indicated.
After incubation, muscles were harvested, washed in ice-cold
Krebs-Henseleit buffer, blotted on filter paper, and quickly
frozen in liquid nitrogen and stored at 80 C. Blood was
collected from the same cohort of mice for the analysis of
insulin, leptin, resistin, serum monocyte chemotactic pro-
tein-1, total plasminogen activator inhibitor (tPAI)-1, TNF,
and IL-6 using a LINCOplex (Linco Research, St. Charles,
MO) mouse adipokine kit, according to the manufacturer’s
instructions. The concentrations of monocyte chemotactic
protein-1, TNF, and IL-6 were below the detection limit of
the kit in / mice. Serum adiponectin was analyzed in female
l/l mice using a kit from R&D Systems (Minneapolis, MN).
Euglycemic-hyperinsulinemic clamp in conscious
mice
Glucose turnover rate and hepatic glucose production were
determined as previously described (26). Glucose turnover rate
was measured in the basal state and during euglycemic-hyper-
insulinemic conditions, using a constant infusion of [3-3H]glu-
cose (2.5 Ci bolus and a flow rate of 0.09 Ci/min). Basal
glucose production and utilization were assessed 65–75 min after
the start of the tracer infusion. At 75 min, a euglycemic-hyper-
insulinemic clamp was started. A priming dose of insulin (female
mice 12.5 mU/kg; male mice 25 mU/kg) was administered, fol-
lowed by a constant infusion of insulin (female mice: infusion
rate 1.25 mU/kg  min and male mice: infusion rate 2.5 mU/
kg  min). At steady state, (75 min after the start of the insulin
infusion), blood samples were taken to measure whole-body glu-
cose utilization and hepatic glucose production. Hepatic glucose
production was determined by subtracting the average glucose
infusion rate from the glucose utilization. Animals were eutha-
nized by an overdose of sodium pentobarbital. Blood samples
were collected to determine the insulin concentration during the
clamp (ultrasensitive insulin ELISA kit; Crystal Chem). Liver was
collected and immediately frozen in liquid nitrogen for analysis
of insulin signaling. In a separate cohort of female mice, the
insulin infusion was terminated after 10 min, and liver was dis-
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sected for analysis of insulin signaling. Initial clamps in male mice
with a 1.25 mU/kg  min insulin infusion rate suggested a greater
hepatic insulin resistance in male compared with female mice.
Therefore, male mice were clamped at a higher infusion rate (2.5
mU/kg  min) than the female mice.
In vivo insulin signaling
Mice (/ and l/l) were fasted for 4 h and then injected with
insulin (0.25 mU/kg, ip). In a separate cohort, mice were injected
with saline or 0.1 mU/g insulin. After 10 min, mice were eutha-
nized with CO2 and liver was dissected and immediately frozen
in liquid nitrogen.
Tissue preparation
Muscle and liver were homogenized in ice-cold buffer [137
mmol/liter NaCl, 20 mmol/liter Tris (pH 7.8), 2.7 mmol/liter
KCl, 10% glycerol, 5 mmol/liter sodium pyrophosphate, 1%
Triton X-100, 1 mmol/liter MgCl2, 10 mmol/liter sodium fluo-
ride, 1 mmol/liter EDTA, 0.2 mmol/liter phenylmethylsulfonyl
fluoride, 1 g/ml aprotinin, 1 g/ml leupeptin, 0.5 mmol/liter
Na3VO4]. Homogenates were rotated end over end for 1 h at 4
C and then subjected to centrifugation (12,000  g for 15 min at
4 C), and the supernatant was collected. Protein content in the
supernatant was measured using the bicinchoninic acid method
(Pierce, Rockford, IL).
Immunoblot analysis
Muscle and liver lysates were adjusted to equal protein con-
centration and heated in Laemmli buffer. Samples for insulin
receptor and insulin receptor substrate (IRS)-1 tyrosine phos-
phorylation were immunoprecipitated with phosphotyrosine
antibody and Dynabeads Protein A (Invitrogen, Carlsbad, CA).
Proteins were separated by SDS-PAGE and transferred to poly-
vinylidene difluoride membrane (Immobilon transfer mem-
brane; Millipore, Billerica, MA). Membranes were blocked in a
buffer of 10 mmol/liter Tris-base, 150 mmol/liter NaCl, and
0.25% Tween 20 containing 7.5% milk for 1 h at room tem-
perature. Membranes were then incubated with primary anti-
bodies overnight at 4 C, followed by incubation with an appro-
priate horseradish peroxidase-conjugated secondary antibody
(Bio-Rad Laboratories, Hercules, CA) for 1 h at room temper-
ature. Bands were visualized using enhanced chemiluminescence
(GE Healthcare Europe GmbH, Germany). Immunoreactive
proteins were quantified using densitometry.
RNA extraction and gene expression analysis
mRNA expression was assessed in liver from 4-h-fasted mice
using quantitative RT-PCR (ABI PRISM 7000 sequence detector
system; Applied Biosystems, Foster City, CA). Total RNA was
purified from liver using Trizol reagent (Invitrogen). RNA was
treated with deoxyribonuclease I using a DNA-free kit (Ambion,
Huntingdon, UK), and cDNA was synthesized using a Super-
Script first-strand synthesis system (Invitrogen). TaqMan gene
expression assays from Applied Biosystems for Pck-1;
(Mm00440636_m1), G6pc; (Mm00839363_m1), and Scd-1
(Mm00772290_m1) were used with glyceraldehyde-3-phos-
phate dehydrogenase (Gapdh) as a reference gene. The mRNA
expression was calculated using the Ct method as described by
Applied Biosystems.
Glycogen and triglyceride analyses
A separate cohort of female mice was fasted for 4 h. Mice were
anesthetized with sodium pentobarbital, and liver was rapidly
removed and frozen in liquid nitrogen. Glycogen content was
determined fluorometrically on HCl extracts as previously de-
scribed (27). Triglycerides were analyzed in pulverized frozen
liver. Tissue was homogenized in 300 l heptan-isopropanol-
Tween mixture (3:2:0.01 by volume) and centrifuged (1500  g
for 15 min at 4 C). Supernatants (upper phase containing ex-
tracted triglycerides) were collected and evaporated by vacuum
centrifugation. Triglyceride content was determined with a trig-
lycerides/glycerol blanked kit (Roche, Basel, Switzerland) using
Seronorm lipid (Sero AS, Billingstad, Norway) as a standard.
Reagents and antibodies
Insulin Actrapid was from Novo Nordisk (Bagsværd, Den-
mark). Horseradish peroxidase-conjugated goat antirabbit and
antimouse IgG was obtained from Bio-Rad Laboratories. Re-
agents for enhanced chemiluminescence were obtained from GE
Healthcare. Bicinchoninic acid protein assay kit was from Pierce.
All other reagents were of analytical grade (Sigma-Aldrich, St.
Louis, MO). Rabbit polyclonal antibodies to glyceraldehyde-3-
phosphate dehydrogenase, Akt, glycogen synthase kinase (GSK)-
3/, IRS-1, phospho-Akt-Ser473, and phospho-GSK-3/-
Ser21/Ser9 were from Cell Signaling Technology, Inc. (Beverly,
MA). Monoclonal 4G10 phosphotyrosine and insulin receptor
antibodies and polyclonal IRS-1 and IRS-2 antibodies were from
Millipore. Phosphoenolpyruvate carboxykinase 1 (PEPCK) an-
tibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). The IRS-1-Tyr612 antibody was from Invitrogen. The glu-
FIG. 1. Glucose homeostasis in l/l mice. Intraperitoneal glucose
tolerance tests were performed in 4-h-fasted / (white bars) and
l/l (black bars) mice. Plasma glucose (mmol/liter) and insulin (pmol/
liter) were analyzed during the glucose tolerance test in female (F; A
and B) and male (M; C and D) / and l/l mice. Results are mean 
SEM. *, P  0.05 vs. /; †, P  0.01 vs. / mice (n  9 –12).
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cose transporter 4 antibody was a kind gift from
Professor Geoffrey Holman (University of Bath,
Bath, UK).
Statistics
Statistical differences were determined by a two-
way ANOVA with multiple comparisons. Student’s
t test was used for comparisons when two parame-
ters were evaluated. Significance was accepted at
P  0.05.
Results
Glucose homeostasis in l/l mice
We have previously shown that the blood
glucose concentration under ad libitum-fed
conditions is normal in female and male l/l
mice. Conversely, insulin level is reduced 40%
in female l/l mice and unaltered in male l/l mice
(24). We determined ip glucose tolerance in
/ and l/l mice. Fasting glucose levels were
normal in female and male l/l mice compared
with age-matched / mice (Fig. 1, A and C).
The glucose profile over 2 h was similar be-
tween female / and l/l mice (Fig. 1A). How-
ever, insulin concentration was reduced at
baseline (P  0.05) and 15 min (P  0.01) after
the glucose injection (Fig. 1B), which indicates
insulin sensitivity is enhanced in female l/l mice
compared with / mice. Interestingly, male
l/l mice have an improved glucose tolerance.
The area under the glucose curve is reduced in
male l/l compared with / mice (/, 2152  80 vs. l/l,
1778  88; P  0.01). The insulin levels are, however,
unaltered both at baseline and 15 min after the glucose
injection in male l/l mice (Fig. 1D).
In vitro glucose transport and insulin signaling in
skeletal muscle
Insulin-stimulated glucose transport was assessed in
isolated skeletal muscle from / and l/l mice. Isolated
EDL and soleus muscles were incubated in vitro without
or with 0.36 and 60 nmol/liter insulin. Basal and insulin-
stimulated glucose transport in isolated EDL and soleus
muscle was similar between female / and l/l mice (Fig.
2, A and B). Despite the improved glucose tolerance ob-
served in the male l/l mice, in vitro insulin-stimulated glu-
cose transport was similar in male / and l/l mice (Sup-
plemental Fig. 1, A and B, published on The Endocrine
Society’s Journals Online web site at http://endo.endo-
journals.org). Consistently, protein expression of the in-
sulin-responsive glucose transporter 4 in EDL and soleus
muscle was similar between / and l/l mice (data not
shown). Moreover, basal and insulin-stimulated phos-
phorylation of Akt-Ser473, a key component in the ca-
nonical insulin signaling pathway controlling glucose up-
take, was similar in EDL and soleus muscle from female
/ and l/l mice (Fig. 2, C and D).
Whole-body insulin sensitivity
We performed a euglycemic-hyperinsulinemic clamp
study, whereby insulin was infused into conscious mice to
assess peripheral glucose utilization and hepatic glucose
production. The glucose turnover rate was similar in fe-
male and male / and l/l mice in the basal state (Fig. 3,
A and C). Both female and male l/l mice had a reduced
body weight compared with / mice, and the clamps
were performed at similar glucose and insulin concentra-
tions (Table 1). In the female mice, the insulin infusion
(1.25 mU/kg  min) increased plasma insulin levels ap-
proximately 2.5-fold. Insulin infusion increased periph-
eral glucose utilization approximately 1.8-fold in both
/ and l/l mice (P  0.01). Furthermore, the insulin
infusion reduced hepatic glucose production 46% in the
FIG. 2. Insulin-stimulated glucose transport in isolated skeletal muscle. Isolated EDL
and soleus muscle from 4-h-fasted female / and l/l mice was incubated in vitro
without and with 0.36 and 60 nmol/liter insulin. Basal and insulin-stimulated in vitro
glucose transport in isolated EDL (A) and soleus (B) muscle from / (white bars)
and l/l (black bars) mice. Basal and insulin-stimulated Akt-Ser473 phosphorylation in
isolated EDL (C) and soleus (D) muscle from female (F) / (white bars) and l/l (black
bars) mice. Results are mean  SEM (n  6–9).
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liver from female / mice (Fig. 3B). In the l/l mice, in-
sulin-induced suppression of hepatic glucose production
was markedly increased (Fig. 3B; P  0.001). Hepatic
glucose production was completely suppressed in the l/l
mice. Thus, hepatic insulin sensitivity is enhanced in fe-
male l/l mice. The male l/l mice also display enhanced he-
patic insulin sensitivity. An insulin infusion (2.5 mU/
kg  min) suppressed hepatic glucose production 74% in
male l/l mice compared with 34% in / mice (Fig. 3D;
P  0.05). Furthermore, the male l/l mice show an in-
creased insulin-stimulated glucose utilization compared
with / mice (Fig. 3C; P  0.01). Enhanced insulin sen-
sitivity is supported by the increased steady-state glucose
infusion rate under the clamp observed in female and male
l/l mice compared with respective / mice (Table 1; P 
0.001). We further report glucose utilization and hepatic
glucose production in a subset of body weight-matched
female and male / and l/l mice. Insulin suppression of
hepatic glucose production is increased (Fig. 3E; P  0.05)
in female l/l mice compared with body weight-matched
/ mice (body weight: /, 19.7  0.8 g vs. l/l, 19.3 
0.5 g). Basal and insulin-stimulated glucose utilization is
similar in female / and l/l mice (Fig. 3F). In the body
weight-matched male / and l/l mice (body weight;
/, 28.0  0.2 g vs. l/l, 27.3  0.3 g), basal glucose
utilization is unaltered (Fig. 3G). There is a trend for in-
FIG. 3. Whole-body glucose utilization in conscious mice. Basal and insulin-stimulated (Rd) peripheral glucose utilization and hepatic glucose
production (Ra) were determined during a euglycemic-hyperinsulinemic clamp in 4-h-fasted / (white bars) and l/l (black bars) mice. Glucose
utilization and the insulin-mediated suppression of hepatic glucose production are presented for female (F; A and B) and male (M; C and D) /
and l/l mice (n  7–9). E–H, A subset of body weight-matched / and l/l mice. Glucose utilization and insulin-mediated suppression of hepatic
glucose production are presented for female (E and F) and male (G and H) / and l/l mice (n  4–5). Results are mean  SEM. *, P  0.05, †,
P  0.01, and #, P  0.001 vs. / mice.
TABLE 1. Basal and clamp characteristics in female and male / and l/l mice
Female Male
/ l/l / l/l
Body weight (g) 20.6  0.5 18.4  0.4a 28.5  0.2 26.6  0.4a
Basal
Plasma glucose (mmol/liter) 8.1  0.7 6.5  0.4 9.0  0.4 8.5  0.6
Plasma insulin (pmol/liter) 86.9  14.1 52.2  6.3b 141.3  21.3 102.8  18.8
Clamp
Plasma glucose (mmol/liter) 6.8  0.5 6.3  0.5 8.6  0.2 8.8  0.4
Plasma insulin (pmol/liter) 191.7  14.1 145.6  13.8 516.7  31.2 471.5  27.0
Glucose infusion rate (mg/kg  min) 28.6  5.0 50.0  1.3c 30.8  3.6 56.2  3.8c
Results are mean  SEM (n  6–10).
a P  0.01 vs. /.
b P  0.05 vs. /.
c P  0.001 vs. /.
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creased insulin-stimulated glucose utilization and the sup-
pression of hepatic glucose production in male l/l mice
(Fig. 3, G and H), which did not reach statistical signifi-
cance in this subset of animals.
Blood chemistry
Blood was collected from 4-h-fasted female and male
/ and l/l mice. Serum leptin concentrations were re-
duced in female and male l/l mice, and insulin concen-
trations were reduced in female l/l mice but unchanged
in male l/l mice (Table 2), consistent with our previous
observations (24). tPAI-1 and resistin were unchanged
in female and male l/l mice. Serum adiponectin levels
were also unaltered between female / and l/l mice.
Signal transduction in the liver
We determined insulin signaling in liver of / and l/l
mice. Liver was collected after approximately 75 min of
insulin infusion during the clamp from male / and l/l
mice. Insulin-stimulated tyrosine phosphorylation of in-
sulin receptor in liver tended to be increased in male l/l
mice compared with / mice (Fig. 4A; P  0.07). Protein
expression of the insulin receptor was, however, similar in
male / and l/l mice (Fig. 4A). Insulin-stimulated ty-
rosine phosphorylation and protein expression of IRS-1
and IRS-2 were similar in male / and l/l mice after the
clamp (Fig. 4, B and C). Insulin-stimulated Akt-Ser473
phosphorylation and protein expression were also unal-
tered between male / and l/l mice (Fig. 4D). Similarly,
tyrosine phosphorylation of insulin receptor, IRS-1, and
IRS-2 and phosphorylation of Akt-Ser473 were not al-
tered in female l/l mice after a 10-min insulin infusion
(Supplemental Fig. 2). We further determined insulin re-
ceptor and IRS-1 tyrosine phosphorylation and Akt-
Ser473 phosphorylation 10 min after a saline or insulin
injection (0.1 mU/g; ip). Basal and insulin-stimulated in-
sulin receptor and IRS-1 tyrosine phosphorylation were
unaltered in liver from female l/l mice (Fig. 5, A and B).
Phosphorylation of IRS-1 at Tyr612 and Akt-Ser473 was
also unchanged in female (Fig. 5, C and D) and male
(Supplemental Fig. 3, A and B) l/l mice, with the excep-
tion of a reduction in Akt-Ser473 phosphorylation in
liver from female l/l mice after saline injection (Fig. 5D;
P  0.05). Protein expression of components of the
early canonical insulin signaling pathway, including the
insulin receptor, IRS-1, and IRS-2, were similar be-
tween female / and l/l mice (Supplemental Fig. 4). In
addition, a low dose of insulin was injected ip and liver
was removed after 10 min for determination of Akt-
Ser473 phosphorylation. Insulin increased Akt-Ser473
phosphorylation 2-fold in / mice (data not shown).
Insulin-stimulated Akt-Ser473 phosphorylation was
unaltered between / and l/l mice (Supplemental Fig.
3C). Moreover, basal phosphorylation of GSK3 at
Ser21 was similar between / and l/l mice (Supple-
mental Fig. 3D). Protein expression of Akt and GSK3
were unchanged between female / and l/l mice (Sup-
plemental Fig. 3, C and D).
Liver composition and expression profile
Aseparate cohortof femalemicewasused toassess liver
glycogen and triglyceride content and gene expression.
Liver glycogen and triglycerides content in 4-h-fasted mice
was similar between / and l/l mice (Table 3). In ad-
dition, hepatic gene expression of the gluconeogenic
enzymes Pck-1 and G6Pc was unaltered between /
and l/l mice (Table 3). We also determined PEPCK pro-
tein expression, which in accordance with the RNA ex-
pression data, was unaltered between / and l/l mice
(data not shown). Although the RNA expression of
Scd-1 was significantly increased in liver from l/l vs.
/ mice (data not shown), SCD-1 protein expression
was unaltered (/, 5.3  0.2 vs. l/l, 5.2  0.3; Sup-
plemental Fig. 5C).
Liver mitochondrial respiratory control in l/l mice
We assessed mitochondrial function in mechanically
permeabilized liver from female / and l/l mice using
high-resolution respirometry to measure electron transfer
and respiratory control through complex I (by adding
TABLE 2. Blood chemistry in 4-h-fasted / and l/l mice
Female Male
/ l/l / l/l
Insulin (pmol/liter) 48.5  2.5 31.9  2.7a 55.0  6.4 52.0  8.0
Leptin (ng/ml) 0.59  0.11 0.22  0.08b 0.94  0.21 0.43  0.11b
Resistin (ng/ml) 1.67  0.08 1.59  0.03 1.41  0.06 1.43  0.05
PAI-1 (ng/ml) 2.43  0.33 2.32  0.40 1.94  0.28 2.64  0.34
Adiponectin (g/ml) 10.8  0.4 11.7  0.6
Results are mean  SEM (n  5–12).
a P  0.001 vs. /.
b P  0.05 vs. /.
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malate, glutamate and pyruvate) and/or complex II (by
supplying succinate). Excess ADP was added to assess
electron transfer coupled to oxidative phosphorylation.
The mitochondrial uncoupler protonophore carboylcya-
nide-4-(trifluoromethoxy)-phenylhydrazone was added
to reach the maximal capacity of the electron transfer sys-
tem. Oxygen flux normalized to liver wet weight (Supple-
mental Fig. 5A) and flux control ratios (Supplemental Fig.
5B) were similar between / and l/l mice. We also de-
termined the protein content of several markers of the
oxidative phosphorylation system, succinate-ubiquinol
oxidoreductase 70-kDa subunit (complex II), cytochrome
oxidase subunit I (complex IV), and ATP synthase sub-
unit-. Consistent with our functional data, the mitochon-
drial protein content was similar between / and l/l mice
(Supplemental Fig. 5C).
Discussion
The absence of leptin or LepRb in ob/ob and
db/db mice leads to the development of insulin
resistance and type 2 diabetes. Leptin regulates
glucose homeostasis indirectly, by regulating
adipose tissue mass, and directly, by acting on
hepatic and peripheral tissues. By using mouse
models with leptin receptor mutations that
block specific leptin receptor signaling path-
ways, we determined pathways important for
the regulation of glucose metabolism. Glucose
homeostasis is improved in LepRb-Tyr1138 mu-
tant mice lacking the LepRb-STAT3 pathway,
compared with db/db mice via a mechanism in-
volving adiposity-dependent and -independent
signals (19).Thephysiological importanceof sig-
nals from the LepRb-Tyr1077/STAT5 pathway,
as well as signals mediated directly by LepRb-
associated Jak2 pathway, in the control of glu-
cose homeostasis is unknown.
We studied female and male l/l mice with
mutant leptin receptors at LepRb-Tyr985 to
assess the physiological role of the LepRb-
SHP2/SOCS3 pathway in glucose homeostasis
(24). The mutant LepRb-Tyr985 receptor
blocks the binding of SOCS3 to the receptor.
SOCS3 is induced by leptin and acts as a neg-
ative regulator of leptin receptor signaling,
thereby promoting leptin resistance (23, 28).
We previously reported that female l/l mice
have reduced body weight due to a reduced
adiposity, whereas male l/l mice have a normal
body weight at 12 wk of age. Circulating leptin
concentrations are appropriately reduced in fe-
male l/l mice. Although the body weight of
male l/l mice is normal at 12 wk of age, leptin
levels are reduced at 8 wk of age, suggesting a modest effect
of Tyr985 mutation on adiposity also in the male l/l mice
(24). We now report that at 15–17 wk of age, male l/l mice
also have reduced body weight. Although glucose toler-
ance is normal in female l/l mice, the reduced insulin con-
centrations in either the fed or the fasted state in these mice
indicate insulin sensitivity is enhanced. Male l/l mice, on
the other hand, show improved glucose tolerance with
unaltered insulin concentrations at baseline and 15 min
after the glucose injection. Although leptin levels are re-
duced in l/l mice (24), adiponectin, resistin, and tPAI-1 are
unaltered. Mice with heterozygous SOCS3 deficiency are
lean and leptin sensitive, similar to the l/l mice. Further-
more, SOCS3 heterozygous mice are protected against de-
velopment of diet-induced obesity and insulin resistance
FIG. 4. Insulin signaling in liver after a euglycemic-hyperinsulinemic clamp. Tyrosine
phosphorylation of insulin receptor (IR) (A), IRS-1 (B), and IRS-2 (C) and
phosphorylation of Akt-Ser473 (D) were determined in liver for male (M) / (white
bars) and l/l (black bars) mice after a clamp (2.5 mU/kg  min insulin infusion).
Representative blots show phosphorylated proteins (top panel) and protein
expression (bottom panel). Results are mean  SEM (n  6–8).
Endocrinology, June 2011, 152(6):2237–2246 endo.endojournals.org 2243
Downloaded from https://academic.oup.com/endo/article-abstract/152/6/2237/2457312
by Universitat de Barcelona. CRAI user
on 17 July 2018
(29, 30). Selective deletion of SOCS3 in proopiomelano-
cortin-expressing cells results in enhanced leptin sensitivity.
On a chow diet, glucose homeostasis was improved despite
no change in body weight (31). Previous reports also show
that mice with a neuronal disruption of SHP2 are obese and
leptin and insulin resistant (32, 33), suggesting that lack of
SOCS3 and not SHP2 is responsible for the improved insulin
sensitivity in l/l mice.
Using the gold standard for analyzing insulin sensitiv-
ity, the euglycemic-hyperinsulinemic clamp, we provide
evidence that whole-body glucose utilization is
unaltered between female and male / and l/l
mice under basal conditions. Although insulin-
stimulated glucose utilization is normal in fe-
male l/l mice, it is enhanced in the male l/l mice.
The improved whole-body glucose utilization
in male l/l mice is further supported by the im-
proved glucose tolerance. However, basal and
insulin-stimulated glucose transport in iso-
lated skeletal muscle is similar between /
and l/l mice. Hepatic insulin sensitivity is en-
hanced in both female and male l/l mice be-
cause insulin-induced suppression of glucose
production was increased, indicating inhibi-
tory leptin signals are important for insulin
sensitivity in liver. To explore the possible in-
fluence of reduced adiposity on glucose utili-
zation and hepatic glucose production, data
from a subset of body weight-matched /
and l/l mice were examined and revealed sim-
ilar results. Thus, the enhanced insulin sensi-
tivity observed in the LepRb-Tyr985 mutant
mice is predominantly primary and not due to
changes in body weight.
The liver plays an important role in the reg-
ulation of glucose metabolism. Glucose pro-
duction from the liver can be controlled from
two simultaneous ongoing pathways. Glucose
is produced by the breakdown of glycogen (gly-
cogenolysis) and by de novo synthesis of glu-
cose (gluconeogenesis) from precursors such as lactate,
amino acids, and glycerol. The contributions of these
pathways for glucose production varies, depending on the
metabolic andnutritional state (34) andmaynotbe similar
in / and l/l mice. Because the suppression of hepatic
glucose production by insulin is markedly improved in l/l
mice, we determined whether changes in glycogen and
triglyceride levels were altered. However, liver glycogen
and triglyceride content was similar between female /
and l/l mice. Thus, the enhanced hepatic insulin sensitivity
is likely to account for the reduction in insulin levels during
the glucose tolerance test in the female l/l mice.
The hypothalamus plays a key role in the regulation of
hepatic glucose production (9, 10). In rats, an acute ad-
ministration of leptin enhances the effect of insulin to in-
hibit glucose production (7). Furthermore, restoration of
hypothalamic leptin action in leptin receptor-deficient Ko-
letsky rats improves hepatic insulin sensitivity by enhanc-
ing the suppression of glucose production (35). The mech-
anism by which hepatic insulin sensitivity is enhanced in l/l
mice is still unclear. Improved leptin sensitivity, as ob-
served in the female l/l mice, could explain the reduction
FIG. 5. Liver signaling. Female (F) / and l/l mice were fasted for 4 h and then
injected with saline (white bars) or insulin (black bars) (0.1 mU/g, ip). Liver was
collected after 10 min. Tyrosine phosphorylation of insulin receptor (IR) (A), IRS-1 (B),
IRS-1-Tyr612 (C), and phosphorylation of Akt-Ser473 (D) were determined.
Representative blots show phosphorylated proteins. Results are mean  SEM.
*, P  0.05 vs. / mice (n  3–6).
TABLE 3. Liver substrates and gene expression in




25.0  3.0 24.8  1.7
Triglycerides
(mg/g tissue)
14.3  0.5 15.7  0.7
Pck-1
(arbitrary units)
2.52  0.23 2.71  0.27
G6pc
(arbitrary units)
1.35  0.21 1.47  0.29
Results are mean  SEM (n  8–12).
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in hepatic glucose production. If this effect is centrally
mediated or is due to direct effects of leptin in the liver
remains to be determined.
To explore the mechanism mediating the enhanced he-
patic insulin sensitivity in l/l mice, early insulin signaling
and expression of key genes were assessed. However, ex-
pression of the gluconeogenic enzymes PEPCK and glu-
cose-6-phosphatase and protein expression and activation
of several early components of the insulin signaling path-
way, including the insulin receptor, IRS-1, and IRS-2,
were unaltered between / and l/l mice. This is in con-
trast to db/db mice that lack the leptin receptor and s/s
mice that lack the LepRb-STAT3 pathway because both of
these models have a pronounced reduction of IRS-2 ex-
pression in the liver (19). Furthermore, db/db and s/s mice
also have an increased expression of stearoyl-coenzyme A
desaturase 1 (SCD-1) in the liver. SCD-1 catalyzes the
synthesis of monounsaturated fatty acids and is regulated
by leptin in the liver (36). Insulin sensitivity is enhanced in
whole-body SCD-1 knockout mice, partly due to reduced
adiposity (37). Although we report that liver Scd-1 mRNA
expression in female l/l mice is increased 2-fold, SCD-1
protein content was unaltered and thus unlikely to play a
role in insulin sensitivity in l/l mice.
Enhanced mitochondrial respiration may also provide
a potential link between hepatic mitochondrial function
and insulin sensitivity. Defective hepatic mitochondrial
function in leptin deficient ob/ob mice is improved by lep-
tin treatment (38). However, female l/l mice have normal
mitochondrial function and protein expression of key mi-
tochondrial proteins such as succinate-ubiquinol oxi-
doreductase 70 kDa subunit, ATP synthase-, and cyto-
chrome oxidase subunit I, indicating the enhanced hepatic
insulin sensitivity may be related to increased parasym-
pathetic nervous system activity, rather than liver-specific
changes in metabolic gene reprogramming.
In addition, changes in glucagon response (39) could
also influence hepatic glucose production. Further-
more, direct intracerebral infusion of nutrients, as well
insulin and leptin, has been shown to decrease hepatic
glucose production (40 – 42). Taken together, given the
unaltered insulin signaling noted in livers from l/l mice,
extrahepatic mechanisms, possibly at the level of the
hypothalamus, may explain the reduction in hepatic
glucose production. Thus, further studies are warranted
to address whether altered hypothalamic insulin signal-
ing in l/l mice alters hepatic tone and insulin suppression
of glucose production.
In conclusion, we report that signals emanating from
the leptin receptor control hepatic insulin sensitivity in
female and male mice. Male mice lacking the LepRb-
Tyr985 pathway also display improved peripheral glucose
utilization. Lack of the LepRb-Tyr985 recruitment of
SHP2/SOCS3 enhances whole-body insulin sensitivity
through increased insulin action on the suppression of
hepatic glucose production. Central leptin and insulin ac-
tion might contribute to the phenotype, but this remains to
be established.
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